Abstract
Objective This review aimed to explore the experiences of nurses working in the field of hematopoietic stem cell transplantation (HSCT) and identify the psychological, emotional, and ethical challenges they face. Given the limited literature specifically focusing on HSCT nurses, this review also includes the experiences of nurses caring for patients with hematologic malignancies in order to provide a comprehensive evaluation of the unique difficulties and coping strategies associated with HSCT.
Introduction Nursing in HSCT requires a high level of specialization and is accompanied by multifaceted challenges, including psychological stress, emotional exhaustion, and ethical dilemmas. HSCT involves destroying the patient’s bone marrow function through intensive chemotherapy and total body irradiation, followed by transplantation of hematopoietic stem cells to restore blood cell production (Kanda, 2015). Introduced in Japan in 1974, more than 5,500 procedures are performed annually. However, life-threatening risks such as graft-versus-host disease (GVHD) and severe infections remain high (Japan Data Center for Hematopoietic Cell Transplantation, 2023).
Nurses face not only technical challenges such as infection prevention and complex treatment management, but also the psychological and emotional burden of supporting patients suffering from severe stress. Many patients struggle with anxiety about relapse, isolation in sterile environments, and long-term psychological burden of recovery. The five-year survival rate for acute myeloid leukemia remains between 44% and 56% (Japan Data Center for Hematopoietic Cell Transplantation, 2023), further exacerbating the difficulties of nursing care due to the severity and complexity of the treatment.
This review examines the challenges faced by nurses in HSCT and hematologic oncology settings using qualitative and mixed methods research to clarify the realities of these experiences. In doing so, it aims to provide insights that can serve as a foundation for future support measures and educational programs.
Inclusion Criteria This review included qualitative and mixed-methods studies focusing on the psychological, emotional, and ethical challenges faced by nurses caring for HSCT and hematologic malignancy patients. Studies targeting pediatric patients and those focusing on professions other than nursing were also excluded.
Methods The primary search engines for this review were PubMed, CINAHL, and Ichushi-Web, and searches were conducted between May and July 2025. The search was limited to the English and Japanese literature. The study selection will involve screening titles and abstracts, followed by a full-text review of relevant studies. Methodological rigor will be critically appraised, and data will be synthesized to identify recurring themes and patterns. The reliability of the findings was evaluated based on the consistency and quality across studies.
PROSPERO Registration Number CRD42024605711
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This study did not receive any funding.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
The Chan Zuckerberg Initiative, Cold Spring Harbor Laboratory, the Sergey Brin Family Foundation, California Institute of Technology, Centre National de la Recherche Scientifique, Fred Hutchinson Cancer Center, Imperial College London, Massachusetts Institute of Technology, Stanford University, University of Washington, and Vrije Universiteit Amsterdam.